Market Overview:
The global endotoxin testing market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for monoclonal antibodies, vaccines, recombinant proteins, cell therapy and gene therapy products. In addition, the growing awareness about food safety and rising number of outbreaks due to microbial contamination are also contributing to the growth of this market. The global endotoxin testing market is segmented on the basis of type, application and region. On the basis of type, it is divided into turbidimetric assays, chromogenic assays rFC assays gel clot assay and others.
Product Definition:
Endotoxin testing is the process of detecting endotoxins in a sample. Endotoxins are toxins that are released by bacteria. They can cause fever, shock, and organ failure. Endotoxin testing is important because it can help identify potentially dangerous bacteria and allow for appropriate treatment.
Turbidimetric:
The global turbidimetric method market size was valued at USD 89.5 million in 2015 and is expected to grow at a CAGR of XX% over the forecast period, owing to its high specificity & sensitivity, ease of use and cost effectiveness as compared to other methods for endotoxin testing.
Chromogenic:
Chromogenic is a new technology that uses color to identify bacteria. It's used in endotoxin testing market because it can differentiate between good and bad bacteria. Chromogenic test is also useful for determining the source of infection, which helps healthcare professionals treat patients more effectively. This technique has replaced the older techniques such as biochemical tests and antibiotic susceptibility tests due to its accuracy and cost-effectiveness benefits.
Application Insights:
Endotoxin testing is used to assess the purity of monoclonal antibodies, vaccines, recombinant proteins and other therapeutic products. The others application segment includes in vitro diagnostic applications. Endotoxin contamination can have a significant impact on the safety and efficacy of pharmaceutical products leading to their withdrawal from the market or suspension. This may result in financial losses for manufacturers as well as consumers. Therefore, it is important for companies to ensure that endotoxin-contaminated drugs do not reach the market by any means possible.
The presence of endotoxins can cause serious diseases such as sepsis, shock and multiple organ failure in humans due to its ability to trigger a systemic inflammatory response which results in extensive tissue damage with release of various cytokines including TNF-alpha & IL-1 beta etc., from activated immune cells (lymphocytes & macrophages).
Regional Analysis:
North America dominated the global endotoxin testing market in 2017. The presence of well-established healthcare infrastructure and high adoption rate for advanced therapeutics are some factors responsible for its large share. Furthermore, increasing prevalence of diseases such as cancer, diabetes, & autoimmune disorders is expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income and improving healthcare facilities in emerging countries such as China & India. In addition, growing focus on developing novel therapies by regulatory agencies will also support regional growth over next eight years.
Growth Factors:
- Increasing incidence of sepsis and other endotoxin-related diseases: The global incidence of sepsis is increasing at a rapid pace. According to the Centers for Disease Control and Prevention (CDC), sepsis affects more than 1 million people in the U.S. every year, resulting in around 270,000 deaths annually. The high mortality rate associated with sepsis is mainly due to the inability of doctors to detect and treat the infection in its early stages. This has led to an increased demand for endotoxin testing products and services worldwide.
- Growing awareness about the benefits of early detection: There is a growing awareness among healthcare professionals about the importance of early detection and treatment of infections caused by endotoxins. This has led to an increase in demand for endotoxin testing products and services worldwide, especially from hospitals and clinics that are looking to improve patient outcomes through earlier diagnosis and treatment of infections caused by these toxins..
Scope Of The Report
Report Attributes
Report Details
Report Title
Endotoxin Testing Market Research Report
By Type
Turbidimetric, Chromogenic, rFC Assays, Gel Clot, Others
By Application
Monoclonal Antibodies, Vaccines, Recombinant Proteins, Cell Therapy, Gene Therapy, Others
By Companies
Lonza, Pacific BioLabs, Charles River, Merck, Eurofins, Medicilon, GenScript, BioMerieux/Hyglos, Accugen Labs, Fujifilm, Steris, Nelson Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Endotoxin Testing Market Report Segments:
The global Endotoxin Testing market is segmented on the basis of:
Types
Turbidimetric, Chromogenic, rFC Assays, Gel Clot, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Monoclonal Antibodies, Vaccines, Recombinant Proteins, Cell Therapy, Gene Therapy, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Lonza
- Pacific BioLabs
- Charles River
- Merck
- Eurofins
- Medicilon
- GenScript
- BioMerieux/Hyglos
- Accugen Labs
- Fujifilm
- Steris
- Nelson Laboratories
Highlights of The Endotoxin Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Turbidimetric
- Chromogenic
- rFC Assays
- Gel Clot
- Others
- By Application:
- Monoclonal Antibodies
- Vaccines
- Recombinant Proteins
- Cell Therapy
- Gene Therapy
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Endotoxin Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Endotoxin testing is a laboratory procedure that measures the amount of endotoxin present in a sample. Endotoxin can be found in many common foods and can cause serious health problems if ingested in large amounts.
Some of the major companies in the endotoxin testing market are Lonza, Pacific BioLabs, Charles River, Merck, Eurofins, Medicilon, GenScript, BioMerieux/Hyglos, Accugen Labs, Fujifilm, Steris, Nelson Laboratories.
The endotoxin testing market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Endotoxin Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Endotoxin Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Endotoxin Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Endotoxin Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Endotoxin Testing Market Size & Forecast, 2018-2028
4.5.1 Endotoxin Testing Market Size and Y-o-Y Growth
4.5.2 Endotoxin Testing Market Absolute $ Opportunity
Chapter 5 Global Endotoxin Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Endotoxin Testing Market Size Forecast by Type
5.2.1 Turbidimetric
5.2.2 Chromogenic
5.2.3 rFC Assays
5.2.4 Gel Clot
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Endotoxin Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Endotoxin Testing Market Size Forecast by Applications
6.2.1 Monoclonal Antibodies
6.2.2 Vaccines
6.2.3 Recombinant Proteins
6.2.4 Cell Therapy
6.2.5 Gene Therapy
6.2.6 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Endotoxin Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Endotoxin Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Endotoxin Testing Analysis and Forecast
9.1 Introduction
9.2 North America Endotoxin Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Endotoxin Testing Market Size Forecast by Type
9.6.1 Turbidimetric
9.6.2 Chromogenic
9.6.3 rFC Assays
9.6.4 Gel Clot
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Endotoxin Testing Market Size Forecast by Applications
9.10.1 Monoclonal Antibodies
9.10.2 Vaccines
9.10.3 Recombinant Proteins
9.10.4 Cell Therapy
9.10.5 Gene Therapy
9.10.6 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Endotoxin Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Endotoxin Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Endotoxin Testing Market Size Forecast by Type
10.6.1 Turbidimetric
10.6.2 Chromogenic
10.6.3 rFC Assays
10.6.4 Gel Clot
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Endotoxin Testing Market Size Forecast by Applications
10.10.1 Monoclonal Antibodies
10.10.2 Vaccines
10.10.3 Recombinant Proteins
10.10.4 Cell Therapy
10.10.5 Gene Therapy
10.10.6 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Endotoxin Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Endotoxin Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Endotoxin Testing Market Size Forecast by Type
11.6.1 Turbidimetric
11.6.2 Chromogenic
11.6.3 rFC Assays
11.6.4 Gel Clot
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Endotoxin Testing Market Size Forecast by Applications
11.10.1 Monoclonal Antibodies
11.10.2 Vaccines
11.10.3 Recombinant Proteins
11.10.4 Cell Therapy
11.10.5 Gene Therapy
11.10.6 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Endotoxin Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Endotoxin Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Endotoxin Testing Market Size Forecast by Type
12.6.1 Turbidimetric
12.6.2 Chromogenic
12.6.3 rFC Assays
12.6.4 Gel Clot
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Endotoxin Testing Market Size Forecast by Applications
12.10.1 Monoclonal Antibodies
12.10.2 Vaccines
12.10.3 Recombinant Proteins
12.10.4 Cell Therapy
12.10.5 Gene Therapy
12.10.6 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Endotoxin Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Endotoxin Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Endotoxin Testing Market Size Forecast by Type
13.6.1 Turbidimetric
13.6.2 Chromogenic
13.6.3 rFC Assays
13.6.4 Gel Clot
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Endotoxin Testing Market Size Forecast by Applications
13.10.1 Monoclonal Antibodies
13.10.2 Vaccines
13.10.3 Recombinant Proteins
13.10.4 Cell Therapy
13.10.5 Gene Therapy
13.10.6 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Endotoxin Testing Market: Competitive Dashboard
14.2 Global Endotoxin Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Lonza
14.3.2 Pacific BioLabs
14.3.3 Charles River
14.3.4 Merck
14.3.5 Eurofins
14.3.6 Medicilon
14.3.7 GenScript
14.3.8 BioMerieux/Hyglos
14.3.9 Accugen Labs
14.3.10 Fujifilm
14.3.11 Steris
14.3.12 Nelson Laboratories
